4.6 Review

The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer

Related references

Note: Only part of the references are listed.
Review Biochemical Research Methods

A roadmap for multi-omics data integration using deep learning

Mingon Kang et al.

Summary: High-throughput next-generation sequencing allows for the generation of large amounts of multi-omics data, which has revolutionized biomedical research by providing a more comprehensive understanding of biological systems and disease development mechanisms. Deep learning algorithms have emerged as a promising method in multi-omics data analysis due to their predictive performance and ability to capture nonlinear and hierarchical features. However, integrating and translating multi-omics data into functional insights remains a challenge, but there is a clear trend towards incorporating multi-omics analysis in biomedical research to explain complex relationships between molecular layers.

BRIEFINGS IN BIOINFORMATICS (2022)

Article Biochemistry & Molecular Biology

HMDB 5.0: the Human Metabolome Database for 2022

David S. Wishart et al.

Summary: The Human Metabolome Database (HMDB) has been providing comprehensive information about human metabolites since 2007, and has undergone significant improvements and upgrades in its latest update, HMDB 5.0. These improvements include an increase in the number of metabolite entries, enhancements to metabolite descriptions, new visualization tools, and more accurately predicted spectral data sets. These upgrades are aimed at improving the usability and potential applications of the HMDB in various fields, including human metabolomics, exposomics, lipidomics, nutritional science, biochemistry, and clinical chemistry.

NUCLEIC ACIDS RESEARCH (2022)

Review Cell Biology

Lactate shuttle: from substance exchange to regulatory mechanism

Xingchen Wang et al.

Summary: Lactate shuttle, as a core mechanism in cancer cell metabolic reprogramming, plays a crucial role in maintaining the growth and metabolism of cancer cells in different types of cancers. The exchange of lactate between cancer cells and tumor microenvironment via MCTs is essential for the energy metabolism of cancer cells.

HUMAN CELL (2022)

Article Oncology

Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer

Xiaoying Wang et al.

Summary: This study found that prostate cancer patients have significantly higher levels of lipoproteins, apolipoproteins, triglycerides, and free fatty acids in their blood. Furthermore, the expression of certain genes related to fatty acid metabolism and cholesterol synthesis is also higher in prostate cancer tissues and positively correlated with the severity of cancer. Mouse models showed that overexpression of fatty acid synthase and knockout of cholesterol efflux pump resulted in the progression of prostate cancer, accompanied by an increase in cancer stem cells and activation of specific signaling pathways. These findings suggest that the combination of fatty acid and cholesterol may contribute to the rising incidence of prostate cancer, and reducing fat and cholesterol intake could slow down disease progression.

NEOPLASIA (2022)

Article Oncology

Outcomes of Screening for Prostate Cancer Among Men Who Use Statins

Arla Vettenranta et al.

Summary: Statin use affects the outcomes of PSA screening, with reduced incidence of advanced prostate cancer among statin users compared to nonusers, but similar detection rates for low-grade localized tumors.

JAMA ONCOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D 1H MRSI without water-signal suppression

Nassim Tayari et al.

Summary: This study investigates the feasibility of water-unsuppressed MRSI in patients with prostate cancer for spectral quality improvement and absolute tissue choline level determination. Results show significantly higher choline tissue concentrations in tumorous areas compared to benign tissue, with choline mapping potentially serving as a tool for tumor localization. This technique enables improved spectral quality and absolute metabolite quantification for prostate cancer diagnosis and biopsy procedures.

MAGNETIC RESONANCE IN MEDICINE (2022)

Article Oncology

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer

Carolin Eckhardt et al.

Summary: In high-risk prostate cancer patients, high SOAT1 expression is strongly associated with shorter BCR-free survival, while SOAT2 expression is not significant. High SOAT1 expression remains significantly associated with shorter BCR-free survival after multivariable adjustment, suggesting SOAT1 may serve as a histologic marker of prognosis and a potential treatment target in the future.

PROSTATE CANCER AND PROSTATIC DISEASES (2022)

Review Biochemical Research Methods

Deep learning meets metabolomics: a methodological perspective

Partho Sen et al.

Summary: The study discusses the application of deep learning in metabolomics, focusing on its role in addressing bottlenecks in data acquisition, processing, metabolite identification, and biomarker discovery. It also examines how deep learning is used in genome-scale metabolic modeling and interpreting metabolomics data, emphasizing its potential to assist computational biologists in integrating, predicting, and drawing statistical inference about biological outcomes based on metabolomics data.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Biochemical Research Methods

Detection of the selective androgen receptor modulator GSK2881078 and metabolites in urine and hair after single oral administration

Alina Rading et al.

Summary: The study examined the hair and urine concentrations of the nonsteroidal selective androgen receptor modulator GSK2881078, finding that peak urinary concentration was observed after 8 hours, while the concentration in hair reached its peak 3 weeks post administration and rapidly declined to trace amounts.

DRUG TESTING AND ANALYSIS (2021)

Article Geriatrics & Gerontology

The gut microbiome-derived metabolite trimethylamineN-oxide modulates neuroinflammation and cognitive function with aging

Vienna E. Brunt et al.

Summary: The study identified TMAO as a potential factor contributing to age-related neuroinflammation and cognitive decline. Experiments in humans and mice showed a positive correlation between TMAO levels and cognitive decline and increased neuroinflammation. Furthermore, the research demonstrated that TMAO can directly activate astrocytes, leading to neuroinflammation.

GEROSCIENCE (2021)

Article Chemistry, Analytical

Single cell metabolomics using mass spectrometry: Techniques and data analysis

Renmeng Liu et al.

Summary: Single cell metabolomics using mass spectrometry techniques explores cellular metabolism, focusing on cell differences at single-cell level, and is expected to have more potential applications in translational and clinical fields with the implementation of advanced data analysis methods.

ANALYTICA CHIMICA ACTA (2021)

Article Chemistry, Analytical

Representing the Metabolome with High Fidelity: Range and Response as Quality Control Factors in LC-MS-Based Global Profiling

Caroline J. Sands et al.

Summary: Liquid chromatography-mass spectrometry (LC-MS) is a powerful technique for measuring chemical species in living systems, with great promise for biomarker discovery. Global metabolic profiling applications yield complex data sets with quality issues that are often overlooked but essential for accurate metabolome representation.

ANALYTICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Thalidomide and its metabolite 5-hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF

Satoshi Yamanaka et al.

Summary: Thalidomide induces teratogenic effects by degrading the PLZF protein, which has been identified as a CRBN substrate, shedding light on the receptor and mechanism of thalidomide-induced teratogenicity.

EMBO JOURNAL (2021)

Article Urology & Nephrology

The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy

Robert J. Hamilton et al.

Summary: This study found a favorable association between statin use and improved overall survival and PCa-specific survival in men undergoing ADT, as well as a trend towards longer treatment interruption time in the IAD arm.

EUROPEAN UROLOGY (2021)

Article Genetics & Heredity

Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer

Yifei Cheng et al.

Summary: This study systematically evaluated the association of SNPs in 21 cholesterol biosynthesis pathway genes with the risk of prostate cancer (PCa) and found that the T allele of rs67415672 in HMGCS1 is a significant protective allele of PCa. The expression of HMGCS1 was significantly decreased in PCa primary tumors compared to normal tissues, indicating that rs67415672 might be a possible functional susceptibility loci for PCa.
Review Immunology

Modification of Proteins by Metabolites in Immunity

C. Diskin et al.

Summary: Immunometabolism has become a focus for immunologists, with metabolic changes in immune cells playing a crucial role in specific immune responses. Post-translational modifications of proteins by metabolites, such as those from glycolysis and Krebs cycle pathways, as well as lipids, amino acids, and polyamines, have been found to alter cell phenotype and modulate immunity and inflammation. The potential use of these findings in developing therapeutics for immune-related diseases is being explored.

IMMUNITY (2021)

Article Biochemistry & Molecular Biology

Zinc transporter mutations linked to acrodermatitis enteropathica disrupt function and cause mistrafficking

Eziz Kuliyev et al.

Summary: ZIP4 is responsible for zinc uptake and loss-of-function mutations can cause AE. The study found that AE-causing ECD mutations in hZIP4 abolished zinc transport activity, leading to intracellular mistrafficking and loss of zinc uptake function.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Endocrinology & Metabolism

Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer

Juan M. Jimenez-Vacas et al.

Summary: Prostate cancer is a major cause of cancer-related death globally among males. Research findings suggest that a combination therapy using biguanides and statins can potentially reduce tumor aggressiveness in prostate cancer patients. The study also highlights the strong anti-tumor effects of both types of medications on prostate cancer cells, with a more potent effect observed when they are combined.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Oncology

Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss

Debora C. Bastos et al.

Summary: The loss of PTEN tumor suppressor gene in murine prostate results in stromal proliferation and reactive microinvasion. Genetic ablation of FASN reduces prostate weight and volume, abolishing stromal reaction and cell proliferation associated with PTEN knockout. Inhibition of FASN significantly decreases cellular motility and invasion potential in prostate cancer, suggesting a potential therapeutic target for aggressive prostate cancer driven by PTEN loss.

JOURNAL OF PATHOLOGY (2021)

Article Biochemistry & Molecular Biology

A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer

Krishna B. Singh et al.

Summary: This study reveals a novel metabolic function of c-Myc in regulating fatty acid synthesis in a subset of human prostate cancer. The positive association between Myc expression and key fatty acid synthesis genes was demonstrated using multiple approaches including TCGA dataset analysis, chromatin immunoprecipitation, and targeted metabolomics. The findings suggest that Myc-regulated fatty acid synthesis could be a promising target for therapy and/or prevention of prostate cancer.

ONCOGENE (2021)

Article Multidisciplinary Sciences

The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

Ayesha A. Shafi et al.

Summary: CRY1, a transcriptional coregulator associated with the circadian clock, is identified as a tumor specific regulator of DNA repair. It is androgen-responsive, stabilized by genomic insult, and promotes DNA repair and cell survival through temporal transcriptional regulation. These findings nominate CRY1 as a new therapeutic target for cancer treatment.

NATURE COMMUNICATIONS (2021)

Article Oncology

Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation

Henrique J. Cardoso et al.

Summary: The study revealed that androgens play a crucial role in regulating the metabolism of prostate cancer cells, especially in CRPC cells. Inhibition of glutaminolysis with BPTES reduced the viability and migration of PCa cells, with a more significant effect observed in CRPC cells. Targeting glutaminase may offer a promising approach for the treatment of CRPC.

CELLULAR ONCOLOGY (2021)

Article Computer Science, Interdisciplinary Applications

Convolutional neural network in proteomics and metabolomics for determination of comorbidity between cancer and schizophrenia

Arthur T. Kopylov et al.

Summary: The study used mass spectrometry and metabolomics to analyze cancer and schizophrenia comorbidity, distinguishing between different pathologies using systematic analysis and a 1DCNN model with high accuracy.

JOURNAL OF BIOMEDICAL INFORMATICS (2021)

Article Oncology

Cancers in Agreement? Exploring the Cross-Talk of Cancer Metabolomic and Transcriptomic Landscapes Using Publicly Available Data

Derek van Tilborg et al.

Summary: Changes in metabolism are a well-known characteristic of cancer cells, with different cancer types showing unique metabolic behaviors governed by genetics. This study combines metabolomics and transcriptomics data to describe aberrated pathways across different cancer types, emphasizing the importance of integrating omics levels for a better understanding of cancer characteristics. While cancer is strongly defined by genetic networks, difficulties arise in merging data and using statistical association networks in studying cancer transcriptomics and metabolomics, highlighting the complexity of cancer landscapes.

CANCERS (2021)

Article Medicine, General & Internal

Novel Metabolic Signatures of Prostate Cancer Revealed by 1H-NMR Metabolomics of Urine

Bo Yang et al.

Summary: This study identified guanidinoacetate, phenylacetylglycine, and glycine as potential candidate biomarkers for prostate cancer, with the ability to accurately differentiate patients and show potential differences among different patient subgroups. Pathway enrichment analysis also revealed the potential involvement of Glycine, Serine, and Threonine metabolism in prostate cancer.

DIAGNOSTICS (2021)

Article Chemistry, Analytical

Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine

Andrea Cerrato et al.

Summary: The study focused on analyzing polar and positively charged metabolites in urine samples from benign prostatic hyperplasia and prostatic cancer patients, utilizing an analytical platform with up to 40-fold analyte enrichment. By applying the ROIMCR procedure to complex metabolomics datasets generated by UHPLC-HRMS, differential metabolites were successfully resolved and tentatively identified, underscoring the importance of this approach in cancer biomarker research. The study highlights the significance of previously neglected metabolite classes in cancer biomarker discovery and the value of the proposed methodology.

ANALYTICA CHIMICA ACTA (2021)

Article Biochemical Research Methods

Prediction and collection of protein-metabolite interactions

Tianyi Zhao et al.

Summary: PMI-DB is a freely accessible, comprehensive and accurate resource of PMIs, providing non-interaction samples and supporting deep learning prediction of PMIs, which helps reduce experimental costs and facilitates the construction of more accurate algorithms.

BRIEFINGS IN BIOINFORMATICS (2021)

Review Pharmacology & Pharmacy

The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy

Tao Xie et al.

Summary: The article discusses the relationship between testosterone replacement therapy (TRT) and male testosterone deficiency, as well as the concerns over prostate cancer risk. It emphasizes the safety of TRT in treating symptomatic men with low-risk disease after localized prostate cancer treatment, and reviews the clinical application and potential mechanisms of bipolar androgen therapy (BAT) in treating castration-resistant prostate cancer, pointing out the challenges ahead for its broad application.

DRUG DISCOVERY TODAY (2021)

Review Biochemistry & Molecular Biology

Targeting Mitochondrial Metabolism in Prostate Cancer with Triterpenoids

Kenza Mamouni et al.

Summary: Metabolic reprogramming is a hallmark of malignancy, with recent studies showing that tumor cells depend on both the Warburg effect and mitochondrial metabolism for survival. Targeting mitochondria in cancer cells is an attractive therapeutic strategy, but the metabolic flexibility of cancer cells may lead to resistance mechanisms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Molecular basis of androgen insensitivity syndromes

Nadine C. Hornig et al.

Summary: Complete androgen insensitivity syndrome is characterized by resistance of the body and cells to androgens due to a hemizygous loss of function mutations in the X-chromosomal androgen receptor gene, despite 46, XY gonosomes. Partial forms of PAIS may exhibit varying degrees of virilisation depending on the activity of the androgen receptor. Despite the presence of the same mutation within a family, the phenotypic outcome can still be variable.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)

Article Oncology

Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy

Nicole Prabhu et al.

Summary: The study in a large surgical cohort found that statin use can improve biochemical recurrence-free survival in prostate cancer patients who have undergone radical prostatectomy, but it does not affect overall survival.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Review Oncology

Metabolic Codependencies in the Tumor Microenvironment

Prasenjit Dey et al.

Summary: Cancer cell metabolic reprogramming is driven by signals from both intrinsic and extrinsic factors. Intrinsic signaling maintains the baseline metabolic state, while extrinsic signals fine-tune metabolic processes based on metabolite availability and cellular requirements. Therefore, successful targeting of metabolic pathways will require a nuanced approach based on cancer genotype, tumor microenvironment composition, and tissue location.

CANCER DISCOVERY (2021)

Review Oncology

Targeting undruggable c-Myc protein by synthetic lethality

Chen Wang et al.

Summary: Synthetic lethal screening is a promising method for identifying novel drug targets, particularly for targeting undruggable proteins like c-Myc. Inhibiting important functional nodes related to c-Myc in non-oncogene addicted networks may have catastrophic effects on tumor cells but not on normal cells. This research field has made progress in identifying these functional nodes and holds great potential for potent tumor treatment.

FRONTIERS OF MEDICINE (2021)

Review Oncology

Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration

Laura E. Kane et al.

Summary: Pancreatic cancer (PC) is considered one of the most deadly malignant diseases globally, with nearly 500,000 deaths in 2020. Pancreatic cystic lesions (PCLs) are fluid-filled structures in the pancreas, which can be pre-malignant or non-malignant. Improved diagnostic algorithms are crucial for accurate risk stratification of patients with PCLs and PC.

CANCERS (2021)

Article Oncology

Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment

Linda K. H. Teng et al.

Summary: The study identified reduced expression of the SAMD14 gene in mast cells from prostate cancer patients, which alters their secretions and enhances cancer cell activity. Interactions between mast cells and cancer-associated fibroblasts were found to promote a pro-tumor extracellular matrix and facilitate cancer cell invasion and migration. This highlights the potential of targeting the tumor microenvironment to develop new treatment strategies for prostate cancer and other solid tumors.

CANCERS (2021)

Article Nutrition & Dietetics

Per- and Polyfluoroalkyl Substance Exposure Combined with High-Fat Diet Supports Prostate Cancer Progression

Ozan Berk Imir et al.

Summary: Our study investigated the impact of PFAS exposure and high-fat diet on prostate cancer progression by evaluating metabolic changes. The findings suggest that PFAS exposure may lead to alterations in metabolism and epigenetic states, increasing the risk and aggressiveness of tumors.

NUTRIENTS (2021)

Article Biochemical Research Methods

Bayesian Inference for Integrating Yarrowia lipolytica Multiomics Datasets with Metabolic Modeling

Andrew D. McNaughton et al.

Summary: In order to improve the bioproduction of target metabolites, a study was conducted to identify key enzymes correlated with itaconate production in the oleaginous yeast Yarrowia lipolytica through integrating metabolic model and multiomics measurements, and statistically obtain key correlations between measured enzymes and boundary flux.

ACS SYNTHETIC BIOLOGY (2021)

Review Health Care Sciences & Services

Current State of Omics Biomarkers in Pancreatic Cancer

Beste Turanli et al.

Summary: Pancreatic cancer poses challenges in early diagnosis and personalized treatment, and the use of multi-omics approaches shows promise in discovering new biomarkers for this disease.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Chemistry, Analytical

A Metabolite Array Technology for Precision Medicine

Guoxiang Xie et al.

Summary: The newly developed metabolite array technology allows for efficient and rapid quantitative analysis of metabolites, suitable for different sample types and mass spectrometry systems. Studies using this technology have shown its potential in biomarker discovery and high throughput clinical testing.

ANALYTICAL CHEMISTRY (2021)

Article Chemistry, Analytical

The Role of Raman Spectroscopy Within Quantitative Metabolomics

Cassio Lima et al.

Summary: This review discusses the flourishing development of Raman spectroscopy as a powerful physicochemical technique with broad applications within the life sciences, critiques its use as a tool for quantitative metabolomics, overviews the recent advancements in its identification and quantification of disease biomarkers in liquid biopsies, particularly focusing on surface-enhanced Raman scattering-based methods, and ultimately explores its applications as label-free imaging modalities to study the abundance and distribution of biomolecules in cells and tissues.

ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 14, 2021 (2021)

Article Oncology

Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort

Elodie Jobard et al.

Summary: Perturbations in circulating metabolites were observed in premenopausal but not postmenopausal breast cancer cases. Metabolites such as histidine, N-acetyl glycoproteins, glycerol, and ethanol were associated with breast cancer risk, particularly in the premenopausal subgroup.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Metabolomics in cancer research and emerging applications in clinical oncology

Daniel R. Schmidt et al.

Summary: Cancer has complex effects on cellular and systemic metabolism, with metabolomics playing a crucial role in providing insights for cancer diagnosis, monitoring, and therapy. Advances in technology have expanded the applications of metabolomics in clinical research, with the potential to further enhance cancer patient management in the future.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer

Rafael S. Martinez et al.

Summary: This study identified SLFN5 as a novel regulator of the LAT1 amino acid transporter in castration-resistant prostate cancer (CRPC), contributing to mTORC1 activity. High expression of SLFN5 in CRPC tumors was correlated with poor patient outcome, indicating its clinical relevance as a potential target for CRPC treatment.

CANCER RESEARCH (2021)

Article Oncology

Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial

In Gab Jeong et al.

Summary: The study aimed to evaluate the efficacy of adjuvant atorvastatin in high-risk prostate cancer patients after radical prostatectomy. However, the results showed that 1-year adjuvant use of atorvastatin did not reduce the risk of disease recurrence compared to placebo in this patient population.

CLINICAL CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes

Stefano Salciccia et al.

Summary: Early detection of prostate cancer relies on PSA levels, but it lacks the ability to distinguish between benign and clinically significant forms of the disease. New urinary and serum biomarkers have been developed, but specific guidelines on their use are currently lacking.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects

Reema Singh et al.

Summary: Prostate cancer is a high-incidence cancer linked to increased mitochondrial metabolic activity. Genomic drivers such as the androgen receptor, c-Myc, PTEN, and p53 are associated with metabolic dysregulation and progression of prostate cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Medical Laboratory Technology

Serum lipids and prostate cancer

Manuel M. Garrido et al.

Summary: Conflicting results have been found in the literature regarding the association between serum lipid levels and prostate cancer. This study found lower LDL and total cholesterol levels in patients with prostate cancer at diagnosis, with no significant differences between risk groups. Low LDL cholesterol and low total cholesterol serum levels seem to be associated with prostate cancer at diagnosis.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Review Biochemistry & Molecular Biology

New Advances in Tissue Metabolomics: A Review

Michelle Saoi et al.

Summary: Metabolomics plays a crucial role in clinical medicine by providing a hypothesis-generating approach for biomarker discovery using human biofluids, while tissue metabolomic studies offer insights into aberrant metabolism at the direct site of disease pathogenesis. Recent advancements in metabolomics have focused on ex vivo analysis, in situ imaging of tissue specimens, and introducing innovative clinical applications for improved cancer screening, diagnostic testing, and therapeutic interventions.

METABOLITES (2021)

Review Biochemistry & Molecular Biology

The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives

Yashwanth Subbannayya et al.

Summary: Rare ovarian cancers have a low incidence rate and poor prognosis; exploring their molecular mechanisms is challenging due to their rarity and fragmented research efforts; omics approaches offer detailed insights into the underlying mechanisms and potential biomarkers for diagnosis and treatment.

BIOMEDICINES (2021)

Review Microbiology

Modulation of Gene Expression in Actinobacteria by Translational Modification of Transcriptional Factors and Secondary Metabolite Biosynthetic Enzymes

Juan F. Martin et al.

Summary: Various post-translational modifications are found in bacteria, such as phosphorylation, acetylation, or phosphopantetheinylation, which play essential roles in bacterial metabolism and secondary metabolite biosynthesis. These modifications can control the activity of key enzymes and transcriptional factors involved in biosynthesis, affecting the expression of genes and production of bioactive metabolites.

FRONTIERS IN MICROBIOLOGY (2021)

Review Biochemistry & Molecular Biology

Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics

Ana Rita Lima et al.

Summary: Prostate cancer is the second most diagnosed cancer in men worldwide. Metabolomics studies have found consistent alterations in specific metabolites in prostate cancer tissue and urine, suggesting the potential for novel biomarker discovery. Valencia, taurine, leucine, and citrate were found to be commonly altered in both urine and tissue studies, indicating a promising strategy for prostate cancer diagnosis.

METABOLITES (2021)

Review Biochemistry & Molecular Biology

Approaches to Integrating Metabolomics and Multi-Omics Data: A Primer

Takoua Jendoubi

Summary: Metabolomics explores the intricate chemical reactions within living organisms and how they are affected by internal and external factors, providing valuable insights into biological functions and mechanisms. Integrating metabolomics data with genomics, transcriptomics, and proteomics information offers unprecedented opportunities for in-depth analysis and discovery of hidden relationships between omics variables.

METABOLITES (2021)

Review Biochemistry & Molecular Biology

Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer

Mio Harachi et al.

Summary: Metabolic reprogramming in cancer cells accelerates metabolism and exploits acetylation to adapt to the microenvironment, influencing protein activity and cellular function. Recent research has highlighted the importance of protein lysine acetylation in oncogenic signaling, offering potential for novel therapeutic strategies against cancer.

METABOLITES (2021)

Article Biochemistry & Molecular Biology

Molecular Dynamic Simulations Suggest That Metabolite-Induced Post-Translational Modifications Alter the Behavior of the Fibrinogen Coiled-Coil Domain

Zofie Sovova et al.

Summary: Fibrinogen is a vital blood plasma protein involved in blood coagulation, and reactions with metabolites can induce post-translational modifications, altering its structure and properties. Certain PTMs were found to suppress fluctuations in specific areas, affecting fibrinolysis and stiffness of the fibrin fibers. The study shows that these PTMs can change the protein's secondary structure, indicating the presence of specific metabolites within the system.

METABOLITES (2021)

Article Chemistry, Analytical

Parallel, High-Quality Proteomic and Targeted Metabolomic Quantification Using Laser Capture Microdissected Tissues

Shichen Shen et al.

Summary: This study presents a novel LC/MS-based approach for parallel global proteomics and targeted metabolomics quantification from the same LCM samples, offering insights into disease mechanisms using prostate cancer patients as a model system. The method enables precise quantification of proteins and androgens, revealing distinct distribution patterns and dysregulated pathways in PCa pathology, with potential for larger-cohort clinical analysis and improved utilization of samples.

ANALYTICAL CHEMISTRY (2021)

Editorial Material Cell Biology

Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization

Anna Mukha et al.

Summary: Prostate cancer's resistance to radiotherapy is a major hurdle in treatment efficacy, with mechanisms driving tumor cell survival and molecular prognostic markers lacking comprehensive understanding.

AUTOPHAGY (2021)

Review Oncology

Metabolic reprogramming in prostate cancer

Fahim Ahmad et al.

Summary: While low-risk localized prostate cancer has a good prognosis with effective treatments, metastatic prostate cancer remains incurable and treatment resistance is a major issue. Resistance is primarily driven by tumor heterogeneity, altered genetic signatures, and metabolic reprogramming enabling tumors to adapt to drugs. Understanding prostate cancer metabolism may offer insights into therapy-induced adaptive responses and more durable therapeutic outcomes.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer

Kangping Xiong et al.

Summary: The study demonstrates that avasimibe can suppress tumor growth and migration through modulation of cell cycle-related proteins and EMT-related proteins via the E2F-1 signaling pathway, indicating its potential as a new effective drug for prostate cancer treatment.

CANCER CELL INTERNATIONAL (2021)

Review Oncology

Amino acid transporters as emerging therapeutic targets in cancer

Yasuhiro Saito et al.

Summary: Amino acids are essential nutrients for both normal and cancer cells. Cancer cells take up amino acids from the surroundings to support rapid proliferation. Amino acids are utilized by cancer cells for protein and nucleotide synthesis, energy production, and have pathological roles as well. The availability of amino acids also affects cell proliferation in cancer cells.

CANCER SCIENCE (2021)

Article Medical Laboratory Technology

GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia

Wenyu Wang et al.

Summary: This study used GC-MS-based untargeted metabolomics, machine learning, and targeted analysis to identify L-serine, myo-inositol, and decanoic acid as potential biomarkers for discriminating prostate cancer from benign prostate hyperplasia. These three metabolites significantly improved the diagnostic accuracy in distinguishing between the two conditions.

CLINICA CHIMICA ACTA (2021)

Review Oncology

Novel insights in cell cycle dysregulation during prostate cancer progression

Salma Ben-Salem et al.

Summary: Prostate cancer remains the second leading cause of cancer deaths in Western men, primarily due to its resistance to available treatments. Understanding the molecular shifts that control cell division and proliferation during prostate cancer progression may help overcome treatment resistance. Various factors, including cell cycle dysregulation, androgen receptor, and somatic alterations, play a role in prostate cancer development and resistance to treatment.

ENDOCRINE-RELATED CANCER (2021)

Article Endocrinology & Metabolism

Targeting Glucocorticoid Metabolism in Prostate Cancer

Shelley Valle et al.

Summary: Resistance to hormonal therapy in the treatment of metastatic prostate cancer is a major obstacle, with some malignancies able to switch from androgen receptor to glucocorticoid receptor signaling. Understanding and targeting the mechanisms enabling this switch shows promise in restoring responsiveness to antiandrogen therapy.

ENDOCRINOLOGY (2021)

Article Biochemistry & Molecular Biology

Sex hormones regulate lipid metabolism in adult Sertoli cells: A genome-wide study of estrogen and androgen receptor binding sites

Sanketa Raut et al.

Summary: The study utilized ChIP-Seq to map estrogen- and androgen-regulated genes in adult Sertoli cells, identifying metabolic pathways as significantly enriched. The research sheds light on the roles of sex hormones in male fertility by elucidating how they regulate lipid metabolism through transcriptional control of related genes.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)

Review Oncology

The implications of IDH mutations for cancer development and therapy

Christopher J. Pirozzi et al.

Summary: The article discusses the impact of IDH mutations in various cancers, highlighting the production of oncometabolite and the importance of targeting mutant IDH for therapeutic purposes. It reviews the current understanding and available data on therapeutic strategies for IDH-mutant cancers and speculates on whether treatment approaches will converge or be context dependent based on the underlying pathogenesis.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone

Tianhong Pan et al.

Summary: The study demonstrates that statins can reduce bone marrow adiposity and slow down the progression of prostate cancer in bones. By affecting the transition of BMSC to adipocytes, the progression of PCa may be delayed.

ONCOGENE (2021)

Article Environmental Sciences

Perfluorinated iodine alkanes induce tissue-specific expression of estrogen receptor and its phosphorylation

Zhihua Ren et al.

Summary: This study investigated the effects of perfluorinated iodine alkanes (PFIs) on the expression and phosphorylation of estrogen receptors (ERs) in human-derived cell lines. The findings revealed a regulatory profile of PFIs on ER isoforms expressions and ER alpha phosphorylation, shedding light on the potential endocrine-disrupting effects of these emerging chemicals. The differential responses in breast cancer and liver cancer cells suggest tissue-specific regulation of ERs by PFIs.

SCIENCE OF THE TOTAL ENVIRONMENT (2021)

Article Multidisciplinary Sciences

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

S. Taavitsainen et al.

Summary: The authors identified chromatin and gene expression patterns in response to enzalutamide treatment in prostate cancer using single cell-ATAC and RNAseq techniques. They found distinct chromatin landscapes associated with treatment and resistance, which could predict treatment response. Ultimately, these findings may inform clinical decision-making by revealing molecular predictors of treatment response in pre-clinical models.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer

C. Kalogirou et al.

Summary: The downregulation of miR-205 promotes cholesterol synthesis and androgen receptor signaling in aggressive prostate cancer by enhancing the expression of the rate-limiting enzyme squalene epoxidase. Overexpression of squalene epoxidase in advanced prostate cancer correlates with poor survival, indicating its potential as a therapeutic target. Inhibition of squalene epoxidase with terbinafine effectively blocked tumor growth in mice and reduced levels of prostate specific antigen in late-stage prostate cancer patients.

NATURE COMMUNICATIONS (2021)

Review Nutrition & Dietetics

Dietary Phytochemicals in Zinc Homeostasis: A Strategy for Prostate Cancer Management

Chandra K. Singh et al.

Summary: Studies have shown the importance of zinc in prostate biology and functions, with high concentrations in healthy prostates and decreased levels in prostate cancer. Zinc supplementation may not effectively increase zinc concentrations in PCa, possibly due to dysregulation of zinc transporters. Natural dietary phytochemicals may modulate zinc levels and combined with zinc, could potentially inhibit prostate cancer.

NUTRIENTS (2021)

Article Multidisciplinary Sciences

High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis

Shi-Ang Qi et al.

Summary: This study identified key metabolites for early lung cancer screening through plasma metabolomic analysis, which could potentially be transferred onto point-of-care devices for lung cancer diagnosis and prognosis.

SCIENTIFIC REPORTS (2021)

Article Biology

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth

Joanna L. Gillis et al.

Summary: The study reveals a novel link between AR and the pentose phosphate pathway in prostate cancer, with AR indirectly increasing 6PGD expression through SREBP1. Targeting 6PGD with specific inhibitors demonstrated anti-cancer activity by inhibiting PPP, increasing AMPK activity, and reducing AR levels and activity. Co-targeting AR and 6PGD showed greater efficacy in inhibiting prostate cancer cell growth compared to single-agent therapies, suggesting a potential therapeutic strategy.

ELIFE (2021)

Article Oncology

Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry

Xiangping Lin et al.

Summary: Correct identification of subjects at high risk is crucial for preventing and screening prostate cancer. Metabolite analysis in biofluids has shown potential in identifying novel biomarkers for PCa. The study found dysregulation of amino acids and sphingolipid metabolism to be associated with future risk of PCa, highlighting 10 specific metabolites.

CANCERS (2021)

Review Oncology

Metabolic Rewiring and the Characterization of Oncometabolites

Diren Beyoglu et al.

Summary: Oncometabolites are produced by cancer cells, facilitating cancer proliferation and progression. Metabolomics, utilizing mass spectrometry platforms, has defined the metabolic changes in cancer cells and uncovered potential oncometabolites.

CANCERS (2021)

Article Biochemistry & Molecular Biology

HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells

Florencia Cascardo et al.

Summary: Prostate cancer is the second most diagnosed malignancy and the fifth leading cause of cancer associated death in men globally. HO-1 induction in PCa cells leads to decreased cellular metabolic rate and changes in clinical outcomes based on LDHA, LDHB, and HMOX1 expression levels.

ANTIOXIDANTS (2021)

Review Biochemistry & Molecular Biology

Metabolomics: A Scoping Review of Its Role as a Tool for Disease Biomarker Discovery in Selected Non-Communicable Diseases

Adewale Victor Aderemi et al.

Summary: Metabolomics is a branch of omics sciences that aims to identify and assess small molecules in samples for their diagnostic and therapeutic potentials. It has been utilized in various aspects of life and has shown potential in biomarker discovery for disease diagnosis and management. However, challenges remain in translating laboratory discoveries to clinical applications.

METABOLITES (2021)

Article Medicine, Research & Experimental

Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes

Sheng-Chieh Hsu et al.

Summary: The study revealed the mechanisms of tumor cell death induced by arginine starvation, including suppression of gene expression, changes in metabolic profiles, and activation of immune responses. The dietary arginine-restriction model demonstrated that arginine starvation can suppress prostate cancer growth and enhance immune cell recruitment.

THERANOSTICS (2021)

Article Oncology

Changes in phospholipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells

Xianlin Yi et al.

Summary: The study reveals differences in lipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells, indicating potential for lipid-based biomarker screening. Phospholipids show varying compositions in exosomes from different cells, highlighting the importance of phosphatidylcholine and lysophosphatidylcholine in hormone-sensitive prostate cancer. Targeting lysophosphatidylcholine, autophagy, and ferroptosis pathways may offer new therapeutic strategies. The modified PEG precipitation technique shows promise for isolating prostate cancer cell exosomes for cancer screening.

JOURNAL OF CANCER (2021)

Article Medical Laboratory Technology

Predictive diagnosis of chronic obstructive pulmonary disease using serum metabolic biomarkers and least-squares support vector machine

Hong Zheng et al.

Summary: This study identified serum metabolic biomarkers that could be used for the diagnosis of COPD. By utilizing LS-SVM and serum metabolic biomarkers, a classifier with linear and polynomial kernels was found to have better accuracy rates and AUC values for COPD diagnosis. Artificial intelligence integrated with serum metabolic biomarkers shows great potential for aiding in COPD diagnosis.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Extraprostatic Uptake of 18F-Fluciclovine: Differentiation of Nonprostatic Neoplasms From Metastatic Prostate Cancer

Matthew S. Robertson et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2020)

Article Chemistry, Analytical

Unveiling the Fragmentation Mechanisms of Modified Amino Acids as the Key for Their Targeted Identification

Maricruz Mamani-Huanca et al.

ANALYTICAL CHEMISTRY (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Chemoproteomic profiling of protein-metabolite interactions

Wei Qin et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Amino acids in cancer

Elizabeth L. Lieu et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Medicine, Research & Experimental

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

Michael A. Kiebish et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Article Multidisciplinary Sciences

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery

Bongyong Lee et al.

SCIENTIFIC REPORTS (2020)

Article Multidisciplinary Sciences

2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer

Arnaud Blomme et al.

NATURE COMMUNICATIONS (2020)

Article Oncology

Targeting RET Kinase in Neuroendocrine Prostate Cancer

Halena R. VanDeusen et al.

MOLECULAR CANCER RESEARCH (2020)

Article Biochemistry & Molecular Biology

STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer

Monika Oberhuber et al.

MOLECULAR SYSTEMS BIOLOGY (2020)

Review Oncology

Proline Metabolism in Tumor Growth and Metastatic Progression

Cristina D'Aniello et al.

FRONTIERS IN ONCOLOGY (2020)

Review Endocrinology & Metabolism

The Role of the Pentose Phosphate Pathway in Diabetes and Cancer

Tongxin Ge et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Biochemical Research Methods

Investigation of spectroscopic and proteomic alterations underlying prostate carcinogenesis

Juliana Felgueiras et al.

JOURNAL OF PROTEOMICS (2020)

Review Biochemistry & Molecular Biology

Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?

Luca Braglia et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)

Article Biochemical Research Methods

Targeted Metabolomics Analyses Reveal Specific Metabolic Alterations in High-Grade Prostate Cancer Patients

Nuria Gomez-Cebrian et al.

JOURNAL OF PROTEOME RESEARCH (2020)

Article Multidisciplinary Sciences

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Jody Vykoukal et al.

NATURE COMMUNICATIONS (2020)

Article Medicine, Research & Experimental

An overview of advances in multi-omics analysis in prostate cancer

Enchong Zhang et al.

LIFE SCIENCES (2020)

Review Oncology

Role of de novo cholesterol synthesis enzymes in cancer

Jie Yang et al.

JOURNAL OF CANCER (2020)

Article Medicine, Research & Experimental

The Genomics of Prostate Cancer: A Historic Perspective

Mark A. Rubin et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)

Review Oncology

Mechanisms of PTEN loss in cancer: It's all about diversity

Virginia Alvarez-Garcia et al.

SEMINARS IN CANCER BIOLOGY (2019)

Review Biochemistry & Molecular Biology

Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine

Vladislav Strmiska et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)

Review Oncology

Acyl-Coenzyme A: Cholesterol Acyltransferase Inhibition in Cancer Treatment

Judyta Zabielska et al.

ANTICANCER RESEARCH (2019)

Article Pharmacology & Pharmacy

Emerging Applications of Metabolomics in Clinical Pharmacology

Huanhuan Pang et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Article Biochemistry & Molecular Biology

Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer

Jodi Dougan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Medicine, Research & Experimental

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

Sven Wach et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Review Pathology

The applications of metabolomics in the molecular diagnostics of cancer

Pro Kit Cheung et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)

Review Cell Biology

The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer

Hung-Chi Yang et al.

CELLS (2019)

Article Multidisciplinary Sciences

Systematic identification of metabolites controlling gene expression in E. coli

Martin Lempp et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1

Deven Patel et al.

SCIENTIFIC REPORTS (2019)

Article Oncology

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study

Charleen D. Adams et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)

Article Multidisciplinary Sciences

Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer

Giorgia Zadra et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Biochemistry & Molecular Biology

Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers

Nuria Gomez-Cebrian et al.

METABOLITES (2019)

Review Medicine, General & Internal

Metabolomics Biomarkers of Prostate Cancer: A Systematic Review

Marouane Kdadra et al.

DIAGNOSTICS (2019)

Article Endocrinology & Metabolism

Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer

David A. Bader et al.

NATURE METABOLISM (2019)

Review Cell Biology

AMPK: guardian of metabolism and mitochondrial homeostasis

Sebastien Herzig et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Oncology

Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study

Juzar Jamnagerwalla et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2018)

Article Medicine, Research & Experimental

Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities

Giorgia Zadra et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Editorial Material Cell Biology

Metabolite-Induced Protein Expression Guided by Metabolomics and Systems Biology

Martin Giera et al.

CELL METABOLISM (2018)

Review Pathology

A review of validated biomarkers obtained through metabolomics

Angeles Lopez-Lopez et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)

Review Endocrinology & Metabolism

From correlation to causation: analysis of metabolomics data using systems biology approaches

Antonio Rosato et al.

METABOLOMICS (2018)

Article Biotechnology & Applied Microbiology

Metabolomics activity screening for identifying metabolites that modulate phenotype

Carlos Guijas et al.

NATURE BIOTECHNOLOGY (2018)

Article Genetics & Heredity

An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer

Ming Chen et al.

NATURE GENETICS (2018)

Review Urology & Nephrology

Clinical implications of PTEN loss in prostate cancer

Tamara Jamaspishvili et al.

NATURE REVIEWS UROLOGY (2018)

Review Endocrinology & Metabolism

Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise

K. M. Di Sebastiano et al.

OBESITY REVIEWS (2018)

Article Medicine, Research & Experimental

The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer

Meng Wang et al.

MEDICAL SCIENCE MONITOR (2018)

Review Medicine, General & Internal

The crucial role of multiomic approach in cancer research and clinically relevant outcomes

Miaolong Lu et al.

EPMA JOURNAL (2018)

News Item Multidisciplinary Sciences

Expanded human gene tally reignites debate

Cassandra Willyard

NATURE (2018)

Review Cell Biology

Metabolites as regulators of insulin sensitivity and metabolism

Qin Yang et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Multidisciplinary Sciences

Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma

Maria K. Andersen et al.

SCIENTIFIC REPORTS (2018)

Review Endocrinology & Metabolism

Review of recent developments in GC-MS approaches to metabolomics-based research

David J. Beale et al.

METABOLOMICS (2018)

Article Multidisciplinary Sciences

Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth

Himanshu Arora et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Biochemistry & Molecular Biology

GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells

Ana Rita Lima et al.

METABOLITES (2018)

Review Genetics & Heredity

Beyond genomics: understanding exposotypes through metabolomics

Nicholas J. W. Rattray et al.

HUMAN GENOMICS (2018)

Review Urology & Nephrology

The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside

Jieping Hu et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2017)

Article Medicine, General & Internal

Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study

Pawel Derezinski et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)

Article Multidisciplinary Sciences

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

Amaia Zabala-Letona et al.

NATURE (2017)

Letter Biochemical Research Methods

Systems biology guided by XCMS Online metabolomics

Tao Huan et al.

NATURE METHODS (2017)

Review Reproductive Biology

A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies

Lin Cheng et al.

JOURNAL OF OVARIAN RESEARCH (2017)

Article Oncology

The Metabolic Phenotype of Prostate Cancer

Eric Eidelman et al.

FRONTIERS IN ONCOLOGY (2017)

Article Multidisciplinary Sciences

The early metabolomic response of adipose tissue during acute cold exposure in mice

Xiyuan Lu et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer

Niki Marie i Zacharias et al.

SCIENTIFIC REPORTS (2017)

Article Oncology

Lactic Acidosis in Prostate Cancer: Consider the Warburg Effect

Johannes C. van der Mijn et al.

CASE REPORTS IN ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling

Gina Lee et al.

Review Biochemistry & Molecular Biology

Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples

Tonje H. Haukaas et al.

METABOLITES (2017)

Review Biochemistry & Molecular Biology

Epimetabolites: discovering metabolism beyond building and burning

Megan R. Showalter et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2017)

Review Biochemical Research Methods

The future of NMR-based metabolomics

John L. Markley et al.

CURRENT OPINION IN BIOTECHNOLOGY (2017)

Article Biochemistry & Molecular Biology

The role of mitochondria in metabolism and cell death

Helin Vakifahmetoglu-Norberg et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

INTEGRATE: gene fusion discovery using whole genome and transcriptome data

Jin Zhang et al.

GENOME RESEARCH (2016)

Review Endocrinology & Metabolism

Protein acetylation in metabolism - metabolites and cofactors

Keir J. Menzies et al.

NATURE REVIEWS ENDOCRINOLOGY (2016)

Review Oncology

Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence

Rachel S. Kelly et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)

Meeting Abstract Oncology

Prospective serum metabolomic profiles of prostate cancer by size and extent of primary tumor

Demetrius Albanes et al.

CANCER RESEARCH (2016)

Article Biochemistry & Molecular Biology

Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth

M. Aggarwal et al.

CELL DEATH AND DIFFERENTIATION (2016)

Review Oncology

Metabolic targets for potential prostate cancer therapeutics

Jeffrey Twum-Ampofo et al.

CURRENT OPINION IN ONCOLOGY (2016)

Editorial Material Pathology

Omics for personalized medicine: defining the current we swim in

Rania Ibrahim et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)

Review Cell Biology

Undercover: gene control by metabolites and metabolic enzymes

Jan A. van der Knaap et al.

GENES & DEVELOPMENT (2016)

Review Biochemistry & Molecular Biology

One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling

Joshua M. Corbin et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Biochemical Research Methods

Untargeted Metabolomics Strategies-Challenges and Emerging Directions

Alexandra C. Schrimpe-Rutledge et al.

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2016)

Article Endocrinology & Metabolism

Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy

Basetti Madhu et al.

METABOLOMICS (2016)

Article Multidisciplinary Sciences

Proteogenomics connects somatic mutations to signalling in breast cancer

Philipp Mertins et al.

NATURE (2016)

Article Cell Biology

The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

Veronica Torrano et al.

NATURE CELL BIOLOGY (2016)

Review Biotechnology & Applied Microbiology

Emerging applications of metabolomics in drug discovery and precision medicine

David S. Wishart

NATURE REVIEWS DRUG DISCOVERY (2016)

Review Cell Biology

Metabolomics: beyond biomarkers and towards mechanisms

Caroline H. Johnson et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Article Endocrinology & Metabolism

NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics

Deepak Kumar et al.

PROSTATE (2016)

Review Oncology

Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies

Ana Rita Lima et al.

TRANSLATIONAL ONCOLOGY (2016)

Article Biochemistry & Molecular Biology

A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments

Anthony C. Dona et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)

Review Medicine, General & Internal

Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016

Olga Golubnitschaja et al.

EPMA JOURNAL (2016)

Article Toxicology

A functional variant in miR-143 promoter contributes to prostate cancer risk

Haiyan Chu et al.

ARCHIVES OF TOXICOLOGY (2016)

Review Biochemistry & Molecular Biology

Cancer Metabolomics and the Human Metabolome Database

David S. Wishart et al.

METABOLITES (2016)

Review Oncology

Integration of omics: more than the sum of its parts

Joerg Martin Buescher et al.

CANCER & METABOLISM (2016)

Review Chemistry, Medicinal

Cancer metabolomics in basic science perspective

Hyuknam Kwon et al.

ARCHIVES OF PHARMACAL RESEARCH (2015)

Article Oncology

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia

Guro F. Giskeodegard et al.

BRITISH JOURNAL OF CANCER (2015)

Review Oncology

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

Lei Chang et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)

Review Pathology

Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer

Giuseppe Lucarelli et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)

Article Biochemistry & Molecular Biology

Rewired Metabolism in Drug-resistant Leukemia Cells A METABOLIC SWITCH HALLMARKED BY REDUCED DEPENDENCE ON EXOGENOUS GLUTAMINE

Claudia Staeubert et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemical Research Methods

Can NMR solve some significant challenges in metabolomics?

G. A. Nagana Gowda et al.

JOURNAL OF MAGNETIC RESONANCE (2015)

Review Biochemistry & Molecular Biology

Acyl-CoA:cholesterol acyltransferases (ACATs/SOATs): Enzymes with multiple sterols as substrates and as activators

Maximillian A. Rogers et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)

Review Endocrinology & Metabolism

Metabolomic profiling of hormone-dependent cancers: a bird's eye view

Stacy M. Lloyd et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)

Article Oncology

Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes

Rouhallah Najjar Sadeghi et al.

TUMOR BIOLOGY (2015)

Review Oncology

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

Margaret A. Knowles et al.

NATURE REVIEWS CANCER (2015)

Editorial Material Oncology

Targeting hexokinase 2 in castration-resistant prostate cancer

Yibin Deng et al.

MOLECULAR & CELLULAR ONCOLOGY (2015)

Review Biochemistry & Molecular Biology

Citrate - new functions for an old metabolite

Vito Iacobazzi et al.

BIOLOGICAL CHEMISTRY (2014)

Article Pharmacology & Pharmacy

Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer

Deliang Guo et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

Article Biochemistry & Molecular Biology

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer

Vincent Zecchini et al.

EMBO JOURNAL (2014)

Review Biochemistry & Molecular Biology

Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?

Nelma Pertega-Gomes et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Multidisciplinary Sciences

MS-GF plus makes progress towards a universal database search tool for proteomics

Sangtae Kim et al.

NATURE COMMUNICATIONS (2014)

Article Genetics & Heredity

Transcriptomes and Proteomes Define Gene Expression Progression in Pre-meiotic Maize Anthers

Han Zhang et al.

G3-GENES GENOMES GENETICS (2014)

Review Biochemistry & Molecular Biology

Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective

James Robert Krycer et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)

Review Oncology

Cancer metabolism: Key players in metabolic reprogramming

Tomoyoshi Soga

CANCER SCIENCE (2013)

Review Medical Laboratory Technology

New Opportunities from the Cancer Metabolome

Omran Abu Aboud et al.

CLINICAL CHEMISTRY (2013)

Article Genetics & Heredity

A Genome-Wide Assessment of Variability in Human Serum Metabolism

Mun-Gwan Hong et al.

HUMAN MUTATION (2013)

Article Endocrinology & Metabolism

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells

Silvia Ottaviani et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)

Review Biochemistry & Molecular Biology

Zinc transporters in prostate cancer

M-C Franz et al.

MOLECULAR ASPECTS OF MEDICINE (2013)

Article Endocrinology & Metabolism

Androgens Promote Prostate Cancer Cell Growth through Induction of Autophagy

Yan Shi et al.

MOLECULAR ENDOCRINOLOGY (2013)

Review Endocrinology & Metabolism

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

Jianguo Xia et al.

METABOLOMICS (2013)

Review Biotechnology & Applied Microbiology

Cell Metabolomics

Aihua Zhang et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2013)

Article Multidisciplinary Sciences

Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness

Guro F. Giskeodegard et al.

PLOS ONE (2013)

Review Biochemistry & Molecular Biology

α-Methylacyl-CoA racemase (AMACR): Metabolic enzyme, drug metabolizer and cancer marker P504S

Matthew D. Lloyd et al.

PROGRESS IN LIPID RESEARCH (2013)

Article Endocrinology & Metabolism

Functional p53 determines docetaxel sensitivity in prostate cancer cells

Chengfei Liu et al.

PROSTATE (2013)

Review Medicine, Research & Experimental

Promise of personalized omics to precision medicine

Rui Chen et al.

WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2013)

Article Endocrinology & Metabolism

Biomarker Discovery and Translation in Metabolomics

G. A. Nagana Gowda et al.

CURRENT METABOLOMICS (2013)

Article Biochemistry & Molecular Biology

A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products

James R. Krycer et al.

BIOCHEMICAL JOURNAL (2012)

Review Medical Laboratory Technology

The role of choline in prostate cancer

Hussain Mohamad Awwad et al.

CLINICAL BIOCHEMISTRY (2012)

Article Pharmacology & Pharmacy

Cholesterol and prostate cancer

Kristine Pelton et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

Review Cell Biology

Metaboloepigenetics: Interrelationships between energy metabolism and epigenetic control of gene expression

Dallas R. Donohoe et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2012)

Article Biochemistry & Molecular Biology

Evidence for DNA-Binding Domain-Ligand-Binding Domain Communications in the Androgen Receptor

Christine Helsen et al.

MOLECULAR AND CELLULAR BIOLOGY (2012)

Review Biochemistry & Molecular Biology

LC-MS-based metabolomics

Bin Zhou et al.

MOLECULAR BIOSYSTEMS (2012)

Article Multidisciplinary Sciences

Serine is a natural ligand and allosteric activator of pyruvate kinase M2

Barbara Chaneton et al.

NATURE (2012)

Review Cell Biology

Metabolomics: the apogee of the omics trilogy

Gary J. Patti et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Review Cell Biology

AMPK: a nutrient and energy sensor that maintains energy homeostasis

D. Grahame Hardie et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Review Urology & Nephrology

Metabolomics in the study of kidney diseases

Robert H. Weiss et al.

NATURE REVIEWS NEPHROLOGY (2012)

Review Biochemistry & Molecular Biology

Lipids and prostate cancer

Janel Suburu et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2012)

Article Oncology

The role of zinc transporter ZIP4 in prostate carcinoma

Qi-guang Chen et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)

Review Oncology

Aminopeptidase N (CD13) as a target for cancer chemotherapy

Malin Wickstrom et al.

CANCER SCIENCE (2011)

Article Cell Biology

Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype

Maryam Ahmadian et al.

CELL METABOLISM (2011)

Article Biochemistry & Molecular Biology

The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

Charles E. Massie et al.

EMBO JOURNAL (2011)

Article Biochemistry & Molecular Biology

Zinc is decreased in prostate cancer: an established relationship of prostate cancer!

Leslie C. Costello et al.

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)

Review Oncology

Metabolic alterations and targeted therapies in prostate cancer

Richard Flavin et al.

JOURNAL OF PATHOLOGY (2011)

Article Multidisciplinary Sciences

Human metabolic individuality in biomedical and pharmaceutical research

Karsten Suhre et al.

NATURE (2011)

Article Multidisciplinary Sciences

MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors

Nicola J. Clegg et al.

PLOS ONE (2011)

Article Multidisciplinary Sciences

The Human Serum Metabolome

Nikolaos Psychogios et al.

PLOS ONE (2011)

Article Multidisciplinary Sciences

The Role of the Transcription Factor SIM2 in Prostate Cancer

Bin Lu et al.

PLOS ONE (2011)

Article Pharmacology & Pharmacy

Pharmacometabonomics as an effector for personalized medicine

Jeremy K. Nicholson et al.

PHARMACOGENOMICS (2011)

Article Oncology

Application of metabolomics to prostate cancer

Bruce J. Trock

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)

Review Oncology

Otto Warburg's contributions to current concepts of cancer metabolism

Willem H. Koppenol et al.

NATURE REVIEWS CANCER (2011)

Review Urology & Nephrology

Metabolomics: A Novel Approach to Early and Noninvasive Prostate Cancer Detection

Matthew J. Roberts et al.

KOREAN JOURNAL OF UROLOGY (2011)

Review Cell Biology

The AMPK-FoxO3A axis as a target for cancer treatment

Fulvio Chiacchiera et al.

CELL CYCLE (2010)

Article Chemistry, Medicinal

Vitamin Bs, One Carbon Metabolism and Prostate Cancer

K. V. Donkena et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

BioNumbers-the database of key numbers in molecular and cell biology

Ron Milo et al.

NUCLEIC ACIDS RESEARCH (2010)

Article Multidisciplinary Sciences

miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice

Cyrielle Clape et al.

PLOS ONE (2009)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy

Mark G. Swanson et al.

MAGNETIC RESONANCE IN MEDICINE (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using H-1 HR-MAS spectroscopy of biopsy tissues

May-Britt Tessem et al.

MAGNETIC RESONANCE IN MEDICINE (2008)

Article Biochemical Research Methods

Current Progress in computational metabolomics

David S. Wishart

BRIEFINGS IN BIOINFORMATICS (2007)

Article Biochemistry & Molecular Biology

hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands

Mohamed M. Desouki et al.

MOLECULAR CANCER (2007)

Review Spectroscopy

Mass spectrometry-based omics technologies in cancer diagnostics

Xuewu Zhang et al.

MASS SPECTROMETRY REVIEWS (2007)

Article Chemistry, Analytical

Metabolomics: The greatest omics of them all?

Danielle Ryan et al.

ANALYTICAL CHEMISTRY (2006)

Review Biochemistry & Molecular Biology

Rheostat control of gene expression by metabolites

Andreas G. Ladurner

MOLECULAR CELL (2006)

Article Biochemistry & Molecular Biology

Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues

Keshav K. Singh et al.

MOLECULAR CANCER (2006)

Article Biochemistry & Molecular Biology

Prevalent mutations in prostate cancer

JT Dong

JOURNAL OF CELLULAR BIOCHEMISTRY (2006)

Review Oncology

Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer

Y. Liu

PROSTATE CANCER AND PROSTATIC DISEASES (2006)

Review Pathology

Altered metabolism and mitochondrial genome in prostate cancer

GD Dakubo et al.

JOURNAL OF CLINICAL PATHOLOGY (2006)

Article Endocrinology & Metabolism

Metabolomics: building on a century of biochemistry to guide human health

J. Bruce German et al.

METABOLOMICS (2005)

Article Multidisciplinary Sciences

Control of gene expression by a natural metabolite-responsive ribozyme

WC Winkler et al.

NATURE (2004)

Article Physiology

Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers

RD Palmiter et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)

Article Physiology

The SLC39 family of metal ion transporters

DJ Eide

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)

Review Oncology

Metabolic profiles of cancer cells

JL Griffin et al.

NATURE REVIEWS CANCER (2004)

Article Biochemistry & Molecular Biology

Fatty acid synthase: A metabolic oncogene in prostate cancer?

A Baron et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Androgens, lipogenesis and prostate cancer

JV Swinnen et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)

Review Microbiology

Metabolomics and systems biology: making sense of the soup

DB Kell

CURRENT OPINION IN MICROBIOLOGY (2004)

Review Biotechnology & Applied Microbiology

The challenges of modeling mammalian biocomplexity

JK Nicholson et al.

NATURE BIOTECHNOLOGY (2004)

Article Endocrinology & Metabolism

Direct effect of zinc on mitochondrial apoptogenesis in prostate cells

P Feng et al.

PROSTATE (2002)

Article Toxicology

Genomics and proteomics analysis of acetaminophen toxicity in mouse liver

SU Ruepp et al.

TOXICOLOGICAL SCIENCES (2002)

Review Oncology

The development of androgen-independent prostate cancer

BJ Feldman et al.

NATURE REVIEWS CANCER (2001)

Article Biochemistry & Molecular Biology

Functional expression of the human hZIP2 zinc transporter

LA Gaither et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)